A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year.
The University of Queensland-developed vaccine candidate, applied to the skin via the high-density microarray patch (HD-MAP), has produced a protective immune response in dengue-infected mice.
UQ PhD candidate Jovin Choo said the result could lead to a readily administered vaccine that could help halt the devastation of dengue fever globally.
“Dengue is the most significant mosquito-borne viral disease in the world’s tropical zone, infecting 390 million and killing 25,000 annually, resulting in annual estimated economic cost of $8.9 billion,” Ms Choo said.
“While a dengue vaccine technically already exists, it’s only licensed to be used in certain countries where Dengue virus is endemic – and with restricted use.
“So to properly fight this terrible disease, we’ve engineered a vaccine candidate based on a platform technology that uses an Australian insect virus called Binjari virus.”
UQ researchers merged the Binjari and dengue viruses making what’s known as a chimeric virus – an artificial virus – to build the basis of the vaccine which has resulted in some great benefits.
“For instance, the particles exactly mimic the surface of their dengue counterpart, which induces a strong, authentic and protective immune response,” Ms Choo said.
“Also, it allows us to very easily manufacture high yields of the vaccine candidate in mosquito cell culture.
“And it only grows in insect cells, and not mammalian cells, making it extremely safe.”
UQ’s Dr David Muller, one of the senior authors of the research, said another advantage was that the candidate could offer potent antibody responses when delivered via the UQ-developed, Vaxxas Pty Ltd commercialised, HD-MAP system.
“Using the microarray patch, we’re able to employ needle-free delivery of the vaccine to the immune cell-rich layers of the skin with just a click,” he said.
“This targeted delivery allows us to achieve potent neutralising antibody responses using a fraction of a typical dose delivered by injection.
“The ease of administration, coupled with lower dose amounts means that the patch could provide both an efficient and inexpensive vaccination option.”
UQ’s Dr Jody Hobson-Peters said this was only the start with the research team looking to apply these techniques more widely.
“There are four variations of dengue that are closely related, all of which can cause severe disease,” Dr Peters said.
“So we’re now expanding our ongoing pre-clinical studies to all four of these forms of dengue virus.
“And we’re also looking to adapt this technology to other viruses, like Zika virus, West Nile virus and Japanese encephalitis virus.
“These are daunting diseases but cheap, easy and accessible vaccinations for them might one day be just a click away.”
Original Article: Jab-free dengue immunity could be just a click away
More from: University of Queensland
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
High-density microarray patch
- This needle-free COVID vaccine fights Omicron, Delta better. Know how to use the jab
The Hexapro COVID vaccine was tested using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results showed that the patch is far more effective at neutralising COVID-19 variants.
- This needle-free vaccine fights Covid variants better than traditional ones
Due to the constantly emerging new Covid-19 variants, the currently available vaccines may not be as effective ...
- Vaccine Patch Fights COVID Variants Better Than Needles in Mouse Model
According to a murine study, a needle-free vaccine patch could better fight COVID-19 variants than a traditional needle vaccine.
- The Covid patch more effective than needles
Researchers at the University of Queensland tested Brisbane biotechnology company Vaxxas’ high-density microarray patch on mice – using it to deliver a dose of Hexapro SARS-CoV-2 spike vaccine.
- COVID-19 patch found to be more effective than needles
An Aussie-developed Covid-19 vaccine patch has been found to be far more effective at protecting against new variants of the virus than needles.
Go deeper with Google Headlines on:
High-density microarray patch
Go deeper with Bing News on:
HD-MAP
- Next Generation of Maps for ADAS, Autonomous Vehicles Coming
By 2027, more than 47 million vehicles will rely on increasingly detailed and accurate digital maps to underpin Advanced Driver Assistance Systems or autonomous driving applications. The need for ...
- 5 JRPGs not from Square Enix deserve the HD-2D treatment
Octopath Traveler introduced JRPG fans to this style when it hit the Nintendo Switch in 2018 Since then, two more HD-2D games have been released: Triangle Strategy and Live a Live. Additionally, an HD ...
- New heart mapping system
Three-dimensional maps of the heart are helping physicians to better target areas where irregular heartbeats originate The maps Kingston Health Science Centre’s (KHSC) cardiologists make of patients’ ...
- Global Revenues for Intelligent Speed Assistance and Autonomous Vehicle Maps Will Surpass US$500 Million by 2027
Intelligent Speed Assistance will kickstart a new era for automotive digital maps LONDON, Aug. 4, 2022 /PRNewswire/ -- Over 47 million vehicles in circulation by 2027 will rely on digital ...
- Luokung’s Digital Twin Intelligent Highway Management and Control Platform Passes Expressway Operation Inspection and Expert Committee Review
The platform incorporates Luokung’s patented technology, intelligent digital monitoring and early warning system for severe weather conditions, based on HD Maps, satellite imaging and other ...